Nov 16, 2018
Approved for: 1.5 **
Pulmonary Hypertension is an underrecognized and underdiagnosed medical problem that affects many patients with chronic kidney disease and end stage renal disease. With the advent of new medications that target the Pulmonary vascular circulation, patients are now better able to exercise and engage in physical activity. This activity will supply the learner with a better understanding of the relationship between the kidney and the pulmonary arteries. An overview of the causes of Pulmonary Hypertension, the differentiation in types, and the various treatments available to improve patient quality of life will be discussed.
Faculty: Carl Boethel, MD
Cost: Free for NKF Members / $25 for non-members